Back to UBS Group AG UBS Group AG

NRSNNRSN
17 quarters

Position history for UBS Group AGUBS Group AG's holdings in NEUROSENSE THERAPEUTICS LTD

UBS Group AG holds 108,636 shares of NRSN (NEUROSENSE THERAPEUTICS LTD), worth $78,218 as of 2026-Q2. The position was increased (+121.3% shares).

Current Value

$78,218

Current Shares

108,636

Total Value Change

+$58,218

Total Shares Change

+100,618

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
108,636
+121.3%
$78,2180.0%$0.72
23
2026-Q1
Increased
49,096
+59.0%
$37,0670.0%$0.85
19
2025-Q4
Increased
30,871
+110.6%
$23,7400.0%$0.71
21
2025-Q3
Increased
14,659
+809.9%
$18,3240.0%$1.25
20
2025-Q2
Decreased
1,611
-29.2%
$3,0450.0%$1.90
0
2025-Q1
New
2,275
-
$2,1160.0%$1.00
18
2024-Q2
Exited
0
-100.0%
$00.0%$1.12
0
2024-Q1
Increased
11,928
+117.0%
$21,7090.0%$1.82
21
2023-Q4
Decreased
5,496
-43.1%
$4,3140.0%$0.79
0
2023-Q3
New
9,665
-
$6,8620.0%$0.71
25
2023-Q2
Exited
0
-100.0%
$00.0%$1.44
0
2023-Q1
Increased
4,762
+17.1%
$8,1910.0%$1.70
13
2022-Q4
Increased
4,065
+122.5%
$4,9590.0%$1.22
16
2022-Q3
Decreased
1,827
-86.4%
$3,0000.0%$1.74
0
2022-Q2
Increased
13,428
+612.7%
$45,0000.0%$2.74
22
2022-Q1
Decreased
1,884
-76.5%
$7,0000.0%$4.11
0
2021-Q4
New
8,018
-
$20,0000.0%$2.44
29

Other major holders of NRSN: CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, Hudson Bay Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used